epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Eohilia

budesonide

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  SUSPENSION: 2 mg per 10 mL

eosinophilic esophagitis

[2 mg PO bid x12wk]
Info: avoid food/drink during administration and for at least 30min after each dose

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: avoid use; Info: caution advised if Child-Pugh Class B

Peds Dosing .

Dosage forms:  SUSPENSION: 2 mg per 10 mL

eosinophilic esophagitis

[11 yo and older]
Dose: 2 mg PO bid x12wk; Info: avoid food/drink during administration and for at least 30min after each dose

renal dosing

[see below]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: avoid use; Info: caution advised if Child-Pugh Class B

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@287cf596
  • hypersensitivity to drug or ingredient
  • hepatic impairment, Child-Pugh Class C
  • systemic fungal infection
  • Strongyloides infection
  • cerebral malaria
  • amebiasis, active
  • amebiasis, latent
  • ocular HSV infection
  • abrupt withdrawal (long-term use)
  • caution: hypersensitivity to corticosteroids
  • caution: long-term systemic corticosteroid use, recent
  • caution: peds patients
  • caution: adolescent patients
  • caution: hepatic impairment, Child-Pugh Class B
  • caution: renal impairment
  • caution: immunosuppressed patients
  • caution: infection, active
  • caution: infection risk
  • caution: measles exposure (non-immune patients)
  • caution: varicella exposure (non-immune patients)
  • caution: HTN
  • caution: pheochromocytoma risk
  • caution: CHF
  • caution: MI, recent
  • caution: diabetes mellitus
  • caution: diabetes mellitus family history
  • caution: ulcerative colitis
  • caution: PUD
  • caution: diverticulitis
  • caution: intestinal anastomosis, recent
  • caution: GI perforation risk
  • caution: seizure disorder
  • caution: myasthenia gravis
  • caution: psychiatric disorder
  • caution: thyroid disorder
  • caution: osteoporosis
  • caution: osteoporosis risk
  • caution: cataract
  • caution: glaucoma
  • caution: glaucoma risk

Drug Interactions .

Overview

budesonide

corticosteroid

Interaction Characteristics:
  • CYP3A4 substrate
  • affects growth hormone diagnostic test results
  • binds to anion exchange resin/polymer
  • corticosteroid
  • hyperammonemia
  • hyperglycemic effects
  • hypernatremia
  • hypertensive effects
  • hypokalemia
  • immunomodulatory effects
  • interferes w/ ACTH analog test

Contraindicated

  • adenovirus vaccine, live
  • Eohilia (budesonide)
    +
    adenovirus vaccine, live
    1 interaction

    Contraindicated

    budesonide + adenovirus vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • BCG live intravesical
  • Eohilia (budesonide)
    +
    BCG live intravesical
    1 interaction

    Contraindicated

    budesonide + BCG live intravesical

    contraindicated: combo may incr. risk of disseminated BCG infection; may decr. immune response (immunosuppressive effects)

  • chikungunya vaccine, live
  • Eohilia (budesonide)
    +
    chikungunya vaccine, live
    1 interaction

    Contraindicated

    budesonide + chikungunya vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cholera vaccine, live
  • Eohilia (budesonide)
    +
    cholera vaccine, live
    1 interaction

    Contraindicated

    budesonide + cholera vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dengue vaccine, live
  • Eohilia (budesonide)
    +
    dengue vaccine, live
    1 interaction

    Contraindicated

    budesonide + dengue vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • desmopressin
  • Eohilia (budesonide)
    +
    desmopressin
    1 interaction

    Contraindicated

    budesonide + desmopressin

    DESMOPRESSIN INJECTABLE: contraindicated; OTHER DESMOPRESSIN ROUTES: monitor sodium, BP: combo may incr. risk of HTN, hyponatremia, including life-threatening (additive effects)

  • influenza nasal vaccine, live
  • Eohilia (budesonide)
    +
    influenza nasal vaccine, live
    1 interaction

    Contraindicated

    budesonide + influenza nasal vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • measles/mumps/rubella vaccine, live
  • Eohilia (budesonide)
    +
    measles/ mumps/ rubella vaccine, live
    1 interaction

    Contraindicated

    budesonide + measles/ mumps/ rubella vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rotavirus vaccine, live
  • Eohilia (budesonide)
    +
    rotavirus vaccine, live
    1 interaction

    Contraindicated

    budesonide + rotavirus vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • smallpox vaccine, live
  • Eohilia (budesonide)
    +
    smallpox vaccine, live
    1 interaction

    Contraindicated

    budesonide + smallpox vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate immunologic vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • talimogene laherparepvec
  • Eohilia (budesonide)
    +
    talimogene laherparepvec
    1 interaction

    Contraindicated

    budesonide + talimogene laherparepvec

    contraindicated: combo may incr. risk of disseminated herpetic infection; may decr. immune response (immunosuppressive effects)

  • typhoid vaccine, live
  • Eohilia (budesonide)
    +
    typhoid vaccine, live
    1 interaction

    Contraindicated

    budesonide + typhoid vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • varicella vaccine, live
  • Eohilia (budesonide)
    +
    varicella vaccine, live
    1 interaction

    Contraindicated

    budesonide + varicella vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • yellow fever vaccine, live
  • Eohilia (budesonide)
    +
    yellow fever vaccine, live
    1 interaction

    Contraindicated

    budesonide + yellow fever vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

Avoid/Use Alternative

  • adagrasib
  • Eohilia (budesonide)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    budesonide + adagrasib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • afamitresgene autoleucel
  • Eohilia (budesonide)
    +
    afamitresgene autoleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + afamitresgene autoleucel

    avoid combo: combo may decr. afamitresgene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • aldesleukin
  • Eohilia (budesonide)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    budesonide + aldesleukin

    avoid combo: combo may incr. risk of serious infection; may decr. aldesleukin efficacy (additive effects; antagonistic effects)

  • amphotericin
  • Eohilia (budesonide)
    +
    amphotericin
    1 interaction

    Avoid/Use Alternative

    budesonide + amphotericin

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, cardiac arrhythmias (possible additive effects)

  • arsenic trioxide
  • Eohilia (budesonide)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    budesonide + arsenic trioxide

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • atazanavir
  • Eohilia (budesonide)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    budesonide + atazanavir

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • axicabtagene ciloleucel
  • Eohilia (budesonide)
    +
    axicabtagene ciloleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + axicabtagene ciloleucel

    avoid combo: combo may decr. axicabtagene ciloleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • betamethasone
  • Eohilia (budesonide)
    +
    betamethasone
    1 interaction

    Avoid/Use Alternative

    budesonide + betamethasone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • brexucabtagene autoleucel
  • Eohilia (budesonide)
    +
    brexucabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + brexucabtagene autoleucel

    avoid combo: combo may decr. brexucabtagene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • budesonide
  • Eohilia (budesonide)
    +
    budesonide
    1 interaction

    Avoid/Use Alternative

    budesonide + budesonide

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • ceritinib
  • Eohilia (budesonide)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    budesonide + ceritinib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • Eohilia (budesonide)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    budesonide + chloramphenicol

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • ciltacabtagene autoleucel
  • Eohilia (budesonide)
    +
    ciltacabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + ciltacabtagene autoleucel

    avoid combo unless severe cytokine release syndrome or neurological toxicity tx: combo may decr. ciltacabtagene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • cladribine oral
  • Eohilia (budesonide)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    budesonide + cladribine oral

    use alternative: combo may incr. risk of serious infection (additive effects)

  • clarithromycin
  • Eohilia (budesonide)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    budesonide + clarithromycin

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • cobicistat
  • Eohilia (budesonide)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    budesonide + cobicistat

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • cortisone
  • Eohilia (budesonide)
    +
    cortisone
    1 interaction

    Avoid/Use Alternative

    budesonide + cortisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome and adrenal suppression, serious infection, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • deflazacort
  • Eohilia (budesonide)
    +
    deflazacort
    1 interaction

    Avoid/Use Alternative

    budesonide + deflazacort

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • dexamethasone
  • Eohilia (budesonide)
    +
    dexamethasone
    1 interaction

    Avoid/Use Alternative

    budesonide + dexamethasone

    avoid combo: combo may decr. budesonide levels, efficacy; may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (hepatic metabolism induced; additive effects, duplicate therapy)

  • epinephrine inhaled
  • Eohilia (budesonide)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    budesonide + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fludrocortisone
  • Eohilia (budesonide)
    +
    fludrocortisone
    1 interaction

    Avoid/Use Alternative

    budesonide + fludrocortisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • furosemide
  • Eohilia (budesonide)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    budesonide + furosemide

    use alternative or monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • grapefruit
  • Eohilia (budesonide)
    +
    grapefruit
    1 interaction

    Avoid/Use Alternative

    budesonide + grapefruit

    avoid grapefruit juice: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (GI metabolism inhibited)

  • hydrocortisone
  • Eohilia (budesonide)
    +
    hydrocortisone
    1 interaction

    Avoid/Use Alternative

    budesonide + hydrocortisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • idecabtagene vicleucel
  • Eohilia (budesonide)
    +
    idecabtagene vicleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + idecabtagene vicleucel

    avoid combo: combo may decr. idecabtagene vicleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • idelalisib
  • Eohilia (budesonide)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    budesonide + idelalisib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • itraconazole
  • Eohilia (budesonide)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    budesonide + itraconazole

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • ketoconazole
  • Eohilia (budesonide)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    budesonide + ketoconazole

    avoid combo during and up to 1wk after ketoconazole tx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • levoketoconazole
  • Eohilia (budesonide)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    budesonide + levoketoconazole

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • lifileucel
  • Eohilia (budesonide)
    +
    lifileucel
    1 interaction

    Avoid/Use Alternative

    budesonide + lifileucel

    avoid combo: combo may decr. lifileucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • lisocabtagene maraleucel
  • Eohilia (budesonide)
    +
    lisocabtagene maraleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + lisocabtagene maraleucel

    avoid combo: combo may decr. lisocabtagene maraleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • lonafarnib
  • Eohilia (budesonide)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    budesonide + lonafarnib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • lopinavir/ritonavir
  • Eohilia (budesonide)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    budesonide + lopinavir/ ritonavir

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • lutetium Lu 177 dotatate
  • Eohilia (budesonide)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Avoid/Use Alternative

    budesonide + lutetium Lu 177 dotatate

    avoid repeated high dose budesonide: combo may decr. lutetium Lu 177 dotatate efficacy (subtype 2 somatostatin receptor downregulation)

  • macimorelin
  • Eohilia (budesonide)
    +
    macimorelin
    1 interaction

    Avoid/Use Alternative

    budesonide + macimorelin

    avoid combo or D/C budesonide, allowing sufficient washout time before diagnostic test: combo may interfere with test results (budesonide may affect pituitary secretion of growth hormone)

  • methylprednisolone
  • Eohilia (budesonide)
    +
    methylprednisolone
    1 interaction

    Avoid/Use Alternative

    budesonide + methylprednisolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • midodrine
  • Eohilia (budesonide)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    budesonide + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • mifepristone
  • Eohilia (budesonide)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    budesonide + mifepristone

    avoid combo during and x14 days after daily mifepristone use: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, hypokalemia, other adverse effects; may decr. budesonide efficacy (hepatic metabolism inhibited, additive effects; antagonistic effects)

  • natalizumab
  • Eohilia (budesonide)
    +
    natalizumab
    1 interaction

    Avoid/Use Alternative

    budesonide + natalizumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • nefazodone
  • Eohilia (budesonide)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    budesonide + nefazodone

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • nelfinavir
  • Eohilia (budesonide)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    budesonide + nelfinavir

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • obecabtagene autoleucel
  • Eohilia (budesonide)
    +
    obecabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + obecabtagene autoleucel

    avoid combo unless severe cytokine release syndrome or ICANS tx: combo may incr. risk of serious infection; may decr. obecabtagene autoleucel efficacy (additive effects; antagonistic effects)

  • pimecrolimus topical
  • Eohilia (budesonide)
    +
    pimecrolimus topical
    1 interaction

    Avoid/Use Alternative

    budesonide + pimecrolimus topical

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • posaconazole
  • Eohilia (budesonide)
    +
    posaconazole
    1 interaction

    Avoid/Use Alternative

    budesonide + posaconazole

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, hypokalemia, other adverse effects (hepatic metabolism inhibited, possible additive effects)

  • prednisolone
  • Eohilia (budesonide)
    +
    prednisolone
    1 interaction

    Avoid/Use Alternative

    budesonide + prednisolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome and adrenal suppression, serious infection, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • prednisone
  • Eohilia (budesonide)
    +
    prednisone
    1 interaction

    Avoid/Use Alternative

    budesonide + prednisone

    avoid combo: combo may decr. budesonide levels, efficacy; may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (hepatic metabolism induced; additive effects, duplicate therapy)

  • rabies vaccine
  • Eohilia (budesonide)
    +
    rabies vaccine
    1 interaction

    Avoid/Use Alternative

    budesonide + rabies vaccine

    if possible, avoid high-dose systemic steroid tx or vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • relacorilant
  • Eohilia (budesonide)
    +
    relacorilant
    1 interaction

    Avoid/Use Alternative

    budesonide + relacorilant

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, incl. Cushing syndrome, adrenal suppression, serious infection, other adverse effects; may decr. efficacy of both drugs (hepatic metabolism inhibited, additive effects; antagonistic effects)

  • ribociclib
  • Eohilia (budesonide)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    budesonide + ribociclib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • ritonavir
  • Eohilia (budesonide)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    budesonide + ritonavir

    avoid combo; risk may be lower w/ nirmatrelvir/ritonavir tx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • tipranavir
  • Eohilia (budesonide)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    budesonide + tipranavir

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • tisagenlecleucel
  • Eohilia (budesonide)
    +
    tisagenlecleucel
    1 interaction

    Avoid/Use Alternative

    budesonide + tisagenlecleucel

    avoid combo: combo may decr. tisagenlecleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • triamcinolone
  • Eohilia (budesonide)
    +
    triamcinolone
    1 interaction

    Avoid/Use Alternative

    budesonide + triamcinolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • tucatinib
  • Eohilia (budesonide)
    +
    tucatinib
    1 interaction

    Avoid/Use Alternative

    budesonide + tucatinib

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • vamorolone
  • Eohilia (budesonide)
    +
    vamorolone
    1 interaction

    Avoid/Use Alternative

    budesonide + vamorolone

    avoid combo: combo may decr. budesonide levels, efficacy; may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (hepatic metabolism induced; additive effects, duplicate therapy)

  • voriconazole
  • Eohilia (budesonide)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    budesonide + voriconazole

    avoid combo: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

Monitor/Modify Tx

  • abiraterone acetate
  • Eohilia (budesonide)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    budesonide + abiraterone acetate

    monitor BP, potassium: combo may incr. risk of HTN, hypokalemia (additive effects)

  • acarbose
  • Eohilia (budesonide)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    budesonide + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Eohilia (budesonide)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    budesonide + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • acetazolamide
  • Eohilia (budesonide)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    budesonide + acetazolamide

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • albuterol
  • Eohilia (budesonide)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    budesonide + albuterol

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • albuterol inhaled
  • Eohilia (budesonide)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + albuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • aliskiren
  • Eohilia (budesonide)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    budesonide + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Eohilia (budesonide)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aloe
  • Eohilia (budesonide)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    budesonide + aloe

    monitor potassium w/ aloe laxative doses: combo may incr. risk of hypokalemia (possible additive effects)

  • alogliptin
  • Eohilia (budesonide)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    budesonide + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • amiloride
  • Eohilia (budesonide)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    budesonide + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amlodipine
  • Eohilia (budesonide)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    budesonide + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Eohilia (budesonide)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    budesonide + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • angiotensin II
  • Eohilia (budesonide)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    budesonide + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • anthrax vaccine
  • Eohilia (budesonide)
    +
    anthrax vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + anthrax vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • aprepitant
  • Eohilia (budesonide)
    +
    aprepitant
    1 interaction

    Monitor/Modify Tx

    budesonide + aprepitant

    if aprepitant 3-day regimen, monitor hypercorticism s/sx; aprepitant single dose-regimen OK: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • aprocitentan
  • Eohilia (budesonide)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    budesonide + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Eohilia (budesonide)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + arformoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • armodafinil
  • Eohilia (budesonide)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    budesonide + armodafinil

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • asciminib
  • Eohilia (budesonide)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    budesonide + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asparaginase
  • Eohilia (budesonide)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    budesonide + asparaginase

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • atenolol
  • Eohilia (budesonide)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    budesonide + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atogepant
  • Eohilia (budesonide)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    budesonide + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atomoxetine
  • Eohilia (budesonide)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    budesonide + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Eohilia (budesonide)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    budesonide + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • avacopan
  • Eohilia (budesonide)
    +
    avacopan
    1 interaction

    Monitor/Modify Tx

    budesonide + avacopan

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • axitinib
  • Eohilia (budesonide)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    budesonide + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Eohilia (budesonide)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    budesonide + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bempedoic acid
  • Eohilia (budesonide)
    +
    bempedoic acid
    1 interaction

    Monitor/Modify Tx

    budesonide + bempedoic acid

    monitor tendon rupture s/sx: combo may incr. risk of tendon rupture (additive effects)

  • benazepril
  • Eohilia (budesonide)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    budesonide + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Eohilia (budesonide)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    budesonide + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • berotralstat
  • Eohilia (budesonide)
    +
    berotralstat
    1 interaction

    Monitor/Modify Tx

    budesonide + berotralstat

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • betaxolol
  • Eohilia (budesonide)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    budesonide + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Eohilia (budesonide)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    budesonide + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bexagliflozin
  • Eohilia (budesonide)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    budesonide + bexagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bismuth subsalicylate
  • Eohilia (budesonide)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    budesonide + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Eohilia (budesonide)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    budesonide + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Eohilia (budesonide)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + brigatinib

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • bromocriptine
  • Eohilia (budesonide)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    budesonide + bromocriptine

    monitor glucose in type 2 diabetes mellitus patients: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bumetanide
  • Eohilia (budesonide)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    budesonide + bumetanide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • bupropion
  • Eohilia (budesonide)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    budesonide + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Eohilia (budesonide)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    budesonide + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Eohilia (budesonide)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    budesonide + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Eohilia (budesonide)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    budesonide + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • canagliflozin
  • Eohilia (budesonide)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    budesonide + canagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • Eohilia (budesonide)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    budesonide + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Eohilia (budesonide)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    budesonide + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • captopril
  • Eohilia (budesonide)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    budesonide + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Eohilia (budesonide)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    budesonide + carfilzomib

    consider antiviral prophylaxis; monitor BP, potassium: combo may incr. risk of serious infection, HTN, hypokalemia (additive effects)

  • carglumic acid
  • Eohilia (budesonide)
    +
    carglumic acid
    1 interaction

    Monitor/Modify Tx

    budesonide + carglumic acid

    monitor ammonia levels: combo may decr. carglumic acid efficacy (antagonistic effects)

  • carvedilol
  • Eohilia (budesonide)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    budesonide + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Eohilia (budesonide)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    budesonide + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cetuximab
  • Eohilia (budesonide)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    budesonide + cetuximab

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • chikungunya vaccine
  • Eohilia (budesonide)
    +
    chikungunya vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + chikungunya vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • chlorothiazide
  • Eohilia (budesonide)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    budesonide + chlorothiazide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • chlorthalidone
  • Eohilia (budesonide)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    budesonide + chlorthalidone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • cholestyramine
  • Eohilia (budesonide)
    +
    cholestyramine
    1 interaction

    Monitor/Modify Tx

    budesonide + cholestyramine

    give oral budesonide at least 1h before or 4-6h after each cholestyramine dose: combo may decr. budesonide levels, efficacy (absorption possibly decreased/delayed)

  • ciprofloxacin
  • Eohilia (budesonide)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    budesonide + ciprofloxacin

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • cisplatin
  • Eohilia (budesonide)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    budesonide + cisplatin

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • clevidipine
  • Eohilia (budesonide)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    budesonide + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clofazimine
  • Eohilia (budesonide)
    +
    clofazimine
    1 interaction

    Monitor/Modify Tx

    budesonide + clofazimine

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • clonidine
  • Eohilia (budesonide)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    budesonide + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Eohilia (budesonide)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    budesonide + cocaine

    monitor BP, HR: combo may incr. cocaine levels, risk of HTN, tachycardia, other adverse effects (plasma metabolism possibly inhibited, additive effects)

  • colesevelam
  • Eohilia (budesonide)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    budesonide + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • colestipol
  • Eohilia (budesonide)
    +
    colestipol
    1 interaction

    Monitor/Modify Tx

    budesonide + colestipol

    give oral budesonide at least 1h before or 4h after each colestipol dose: combo may decr. budesonide levels, efficacy (absorption possibly decreased/delayed)

  • conivaptan
  • Eohilia (budesonide)
    +
    conivaptan
    1 interaction

    Monitor/Modify Tx

    budesonide + conivaptan

    monitor hypercorticism s/sx during and x7 days after conivaptan tx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • copanlisib
  • Eohilia (budesonide)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    budesonide + copanlisib

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Eohilia (budesonide)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    budesonide + corticotropin

    monitor BP, potassium: combo may incr. risk of serious infection, HTN, hypokalemia (additive effects)

  • cosyntropin
  • Eohilia (budesonide)
    +
    cosyntropin
    1 interaction

    Monitor/Modify Tx

    budesonide + cosyntropin

    hold budesonide on day of test: combo may interfere with test results (budesonide may alter plasma cortisol levels)

  • COVID-19 vaccine
  • Eohilia (budesonide)
    +
    COVID-19 vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + COVID-19 vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • crizotinib
  • Eohilia (budesonide)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    budesonide + crizotinib

    monitor potassium, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, hypokalemia, other adverse effects (hepatic metabolism inhibited, additive effects)

  • cyclosporine
  • Eohilia (budesonide)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    budesonide + cyclosporine

    monitor BP, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, other adverse effects (hepatic metabolism inhibited, additive effects)

  • danazol
  • Eohilia (budesonide)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    budesonide + danazol

    monitor BP, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, other adverse effects (hepatic metabolism inhibited, additive effects)

  • dapagliflozin
  • Eohilia (budesonide)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    budesonide + dapagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • Eohilia (budesonide)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    budesonide + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darunavir
  • Eohilia (budesonide)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    budesonide + darunavir

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • decitabine
  • Eohilia (budesonide)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    budesonide + decitabine

    monitor potassium w/ IV decitabine use; otherwise, caution advised: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • desvenlafaxine
  • Eohilia (budesonide)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    budesonide + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Eohilia (budesonide)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    budesonide + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Eohilia (budesonide)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    budesonide + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dichlorphenamide
  • Eohilia (budesonide)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    budesonide + dichlorphenamide

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • diclofenac
  • Eohilia (budesonide)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    budesonide + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Eohilia (budesonide)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    budesonide + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Eohilia (budesonide)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    budesonide + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • Eohilia (budesonide)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    budesonide + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • digoxin
  • Eohilia (budesonide)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    budesonide + digoxin

    monitor electrolytes: combo may incr. risk of digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities may incr. digoxin sensitivity)

  • dihydroergotamine
  • Eohilia (budesonide)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    budesonide + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Eohilia (budesonide)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    budesonide + diltiazem

    monitor BP, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

  • dinutuximab
  • Eohilia (budesonide)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    budesonide + dinutuximab

    monitor potassium: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • diphtheria/tetanus vaccine
  • Eohilia (budesonide)
    +
    diphtheria/ tetanus vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + diphtheria/ tetanus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • diphtheria/tetanus/pertussis vaccine
  • Eohilia (budesonide)
    +
    diphtheria/ tetanus/ pertussis vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + diphtheria/ tetanus/ pertussis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • dobutamine
  • Eohilia (budesonide)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    budesonide + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Eohilia (budesonide)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    budesonide + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Eohilia (budesonide)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    budesonide + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Eohilia (budesonide)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    budesonide + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Eohilia (budesonide)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    budesonide + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dronedarone
  • Eohilia (budesonide)
    +
    dronedarone
    1 interaction

    Monitor/Modify Tx

    budesonide + dronedarone

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • droxidopa
  • Eohilia (budesonide)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    budesonide + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • dulaglutide
  • Eohilia (budesonide)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    budesonide + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duvelisib
  • Eohilia (budesonide)
    +
    duvelisib
    1 interaction

    Monitor/Modify Tx

    budesonide + duvelisib

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • ebola vaccine, live
  • Eohilia (budesonide)
    +
    ebola vaccine, live
    1 interaction

    Monitor/Modify Tx

    budesonide + ebola vaccine, live

    consider vaccinating at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response; may incr. risk of mild vesicular stomatitis virus infection (immunosuppressive effects, recombinant vaccine with vesicular stomatitis virus vector)

  • eletriptan
  • Eohilia (budesonide)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • emapalumab
  • Eohilia (budesonide)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    budesonide + emapalumab

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • empagliflozin
  • Eohilia (budesonide)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    budesonide + empagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • enalapril
  • Eohilia (budesonide)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    budesonide + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Eohilia (budesonide)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    budesonide + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Eohilia (budesonide)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    budesonide + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Eohilia (budesonide)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    budesonide + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Eohilia (budesonide)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    budesonide + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Eohilia (budesonide)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    budesonide + epinephrine

    monitor BP, potassium, ECG: combo may incr. risk of HTN, hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • eplerenone
  • Eohilia (budesonide)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    budesonide + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Eohilia (budesonide)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    budesonide + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Eohilia (budesonide)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    budesonide + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Eohilia (budesonide)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    budesonide + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Eohilia (budesonide)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    budesonide + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • ertugliflozin
  • Eohilia (budesonide)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    budesonide + ertugliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • erythromycin
  • Eohilia (budesonide)
    +
    erythromycin
    1 interaction

    Monitor/Modify Tx

    budesonide + erythromycin

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • esketamine
  • Eohilia (budesonide)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    budesonide + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Eohilia (budesonide)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    budesonide + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Eohilia (budesonide)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    budesonide + estetrol (contraceptive)

    monitor BP: combo may alter corticosteroid levels, incr. risk of HTN, other adverse effects or decr. efficacy (altered corticosteroid binding globulin, additive effects)

  • estradiol (contraceptive)
  • Eohilia (budesonide)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    budesonide + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Eohilia (budesonide)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    budesonide + ethacrynic acid

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • Eohilia (budesonide)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    budesonide + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Eohilia (budesonide)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    budesonide + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Eohilia (budesonide)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    budesonide + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Eohilia (budesonide)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    budesonide + etrasimod

    monitor BP; caution advised during and x5wk after etrasimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • everolimus
  • Eohilia (budesonide)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    budesonide + everolimus

    admin. PCP prophylaxis: combo may incr. risk of serious infection (additive effects)

  • exenatide
  • Eohilia (budesonide)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    budesonide + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fedratinib
  • Eohilia (budesonide)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    budesonide + fedratinib

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • felodipine
  • Eohilia (budesonide)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    budesonide + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Eohilia (budesonide)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    budesonide + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Eohilia (budesonide)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    budesonide + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Eohilia (budesonide)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    budesonide + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Eohilia (budesonide)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    budesonide + fingolimod

    monitor BP; caution advised during and x2mo after fingolimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • fluconazole
  • Eohilia (budesonide)
    +
    fluconazole
    1 interaction

    Monitor/Modify Tx

    budesonide + fluconazole

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • flurbiprofen
  • Eohilia (budesonide)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    budesonide + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Eohilia (budesonide)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + formoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • foscarnet
  • Eohilia (budesonide)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    budesonide + foscarnet

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • fosfomycin injection
  • Eohilia (budesonide)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    budesonide + fosfomycin injection

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • fosinopril
  • Eohilia (budesonide)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    budesonide + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Eohilia (budesonide)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Eohilia (budesonide)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    budesonide + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Eohilia (budesonide)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Eohilia (budesonide)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    budesonide + fruquintinib

    monitor BP: combo may incr. risk of serious infection, HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Eohilia (budesonide)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    budesonide + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • glimepiride
  • Eohilia (budesonide)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    budesonide + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Eohilia (budesonide)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    budesonide + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Eohilia (budesonide)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    budesonide + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glycerol phenylbutyrate
  • Eohilia (budesonide)
    +
    glycerol phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    budesonide + glycerol phenylbutyrate

    monitor ammonia levels: combo may decr. budesonide levels, efficacy; may decr. glycerol phenylbutyrate efficacy (hepatic metabolism induced; antagonistic effects)

  • guanfacine
  • Eohilia (budesonide)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    budesonide + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • Haemophilus b vaccine
  • Eohilia (budesonide)
    +
    Haemophilus b vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + Haemophilus b vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis A vaccine
  • Eohilia (budesonide)
    +
    hepatitis A vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + hepatitis A vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis B vaccine
  • Eohilia (budesonide)
    +
    hepatitis B vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + hepatitis B vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hoodia
  • Eohilia (budesonide)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    budesonide + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • human papillomavirus vaccine
  • Eohilia (budesonide)
    +
    human papillomavirus vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + human papillomavirus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hydralazine
  • Eohilia (budesonide)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    budesonide + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Eohilia (budesonide)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    budesonide + hydrochlorothiazide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • hydroxocobalamin IV
  • Eohilia (budesonide)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    budesonide + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibrutinib
  • Eohilia (budesonide)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    budesonide + ibrutinib

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • ibuprofen
  • Eohilia (budesonide)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    budesonide + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • imatinib
  • Eohilia (budesonide)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + imatinib

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • indapamide
  • Eohilia (budesonide)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    budesonide + indapamide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • indomethacin
  • Eohilia (budesonide)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    budesonide + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • influenza H5N1 vaccine
  • Eohilia (budesonide)
    +
    influenza H5N1 vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + influenza H5N1 vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • influenza vaccine
  • Eohilia (budesonide)
    +
    influenza vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + influenza vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response (immunosuppressive effects)

  • insulin
  • Eohilia (budesonide)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    budesonide + insulin

    monitor glucose, potassium: combo may incr. risk of hypokalemia; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • irbesartan
  • Eohilia (budesonide)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    budesonide + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isavuconazonium
  • Eohilia (budesonide)
    +
    isavuconazonium
    1 interaction

    Monitor/Modify Tx

    budesonide + isavuconazonium

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • isoproterenol
  • Eohilia (budesonide)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    budesonide + isoproterenol

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • isradipine
  • Eohilia (budesonide)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    budesonide + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • Japanese encephalitis vaccine
  • Eohilia (budesonide)
    +
    Japanese encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + Japanese encephalitis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ketamine
  • Eohilia (budesonide)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    budesonide + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketoprofen
  • Eohilia (budesonide)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    budesonide + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Eohilia (budesonide)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    budesonide + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Eohilia (budesonide)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    budesonide + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Eohilia (budesonide)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    budesonide + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lefamulin
  • Eohilia (budesonide)
    +
    lefamulin
    1 interaction

    Monitor/Modify Tx

    budesonide + lefamulin

    ORAL LEFAMULIN: monitor hypercorticism s/sx; IV lefamulin use OK: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • leflunomide
  • Eohilia (budesonide)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    budesonide + leflunomide

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • lenacapavir
  • Eohilia (budesonide)
    +
    lenacapavir
    1 interaction

    Monitor/Modify Tx

    budesonide + lenacapavir

    monitor hypercorticism s/sx during and x9mo after lenacapavir tx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • lenalidomide
  • Eohilia (budesonide)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    budesonide + lenalidomide

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • lenvatinib
  • Eohilia (budesonide)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • letermovir
  • Eohilia (budesonide)
    +
    letermovir
    1 interaction

    Monitor/Modify Tx

    budesonide + letermovir

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • levalbuterol inhaled
  • Eohilia (budesonide)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + levalbuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • levomilnacipran
  • Eohilia (budesonide)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    budesonide + levomilnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • licorice
  • Eohilia (budesonide)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    budesonide + licorice

    monitor BP, potassium w/ large amounts of licorice: combo may incr. budesonide levels, duration of action, risk of HTN, hypokalemia, other adverse effects (mechanism unknown; additive effects)

  • linagliptin
  • Eohilia (budesonide)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    budesonide + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • Eohilia (budesonide)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    budesonide + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisdexamfetamine
  • Eohilia (budesonide)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    budesonide + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • Eohilia (budesonide)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    budesonide + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lixisenatide
  • Eohilia (budesonide)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    budesonide + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • Eohilia (budesonide)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + lorlatinib

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • losartan
  • Eohilia (budesonide)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    budesonide + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Eohilia (budesonide)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    budesonide + lumacaftor/ ivacaftor

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • luspatercept
  • Eohilia (budesonide)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    budesonide + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium citrate
  • Eohilia (budesonide)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    budesonide + magnesium citrate

    monitor potassium, consider monitoring ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • magnesium salicylate
  • Eohilia (budesonide)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    budesonide + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • mannitol
  • Eohilia (budesonide)
    +
    mannitol
    1 interaction

    Monitor/Modify Tx

    budesonide + mannitol

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • meclofenamate
  • Eohilia (budesonide)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    budesonide + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Eohilia (budesonide)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    budesonide + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Eohilia (budesonide)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    budesonide + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meningococcal vaccine
  • Eohilia (budesonide)
    +
    meningococcal vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + meningococcal vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • metformin
  • Eohilia (budesonide)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    budesonide + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methamphetamine
  • Eohilia (budesonide)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    budesonide + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methazolamide
  • Eohilia (budesonide)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    budesonide + methazolamide

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Eohilia (budesonide)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    budesonide + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyldopa
  • Eohilia (budesonide)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    budesonide + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Eohilia (budesonide)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    budesonide + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • Eohilia (budesonide)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    budesonide + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Eohilia (budesonide)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    budesonide + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Eohilia (budesonide)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    budesonide + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Eohilia (budesonide)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    budesonide + metolazone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • metoprolol
  • Eohilia (budesonide)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    budesonide + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metyrapone
  • Eohilia (budesonide)
    +
    metyrapone
    1 interaction

    Monitor/Modify Tx

    budesonide + metyrapone

    D/C budesonide 5 half-lives before metyrapone test: combo may alter test results (antagonistic effects, exogenous corticosteroids may interfere with test)

  • miglitol
  • Eohilia (budesonide)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    budesonide + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • Eohilia (budesonide)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    budesonide + milnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • minoxidil
  • Eohilia (budesonide)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    budesonide + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Eohilia (budesonide)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    budesonide + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mitomycin
  • Eohilia (budesonide)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    budesonide + mitomycin

    caution advised; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of serious infection (additive effects)

  • mitotane
  • Eohilia (budesonide)
    +
    mitotane
    1 interaction

    Monitor/Modify Tx

    budesonide + mitotane

    monitor cortisol and corticotropin (ACTH) levels: combo may decr. budesonide levels, efficacy (hepatic metabolism induced, mitotane may cause adrenal insufficiency)

  • modafinil
  • Eohilia (budesonide)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    budesonide + modafinil

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • moexipril
  • Eohilia (budesonide)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    budesonide + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • motixafortide
  • Eohilia (budesonide)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    budesonide + motixafortide

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • nabumetone
  • Eohilia (budesonide)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    budesonide + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Eohilia (budesonide)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    budesonide + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Eohilia (budesonide)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    budesonide + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Eohilia (budesonide)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nateglinide
  • Eohilia (budesonide)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    budesonide + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • naxitamab
  • Eohilia (budesonide)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    budesonide + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Eohilia (budesonide)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    budesonide + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • necitumumab
  • Eohilia (budesonide)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    budesonide + necitumumab

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • netupitant
  • Eohilia (budesonide)
    +
    netupitant
    1 interaction

    Monitor/Modify Tx

    budesonide + netupitant

    monitor hypercorticism s/sx during and x1wk after (fos)netupitant tx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • nicardipine
  • Eohilia (budesonide)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    budesonide + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicotine
  • Eohilia (budesonide)
    +
    nicotine
    1 interaction

    Monitor/Modify Tx

    budesonide + nicotine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nifedipine
  • Eohilia (budesonide)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    budesonide + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Eohilia (budesonide)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    budesonide + nilotinib

    monitor potassium, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, hypokalemia, other adverse effects (hepatic metabolism inhibited, additive effects)

  • nimodipine
  • Eohilia (budesonide)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    budesonide + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Eohilia (budesonide)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    budesonide + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nirogacestat
  • Eohilia (budesonide)
    +
    nirogacestat
    1 interaction

    Monitor/Modify Tx

    budesonide + nirogacestat

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • nisoldipine
  • Eohilia (budesonide)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    budesonide + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Eohilia (budesonide)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    budesonide + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Eohilia (budesonide)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    budesonide + obinutuzumab

    monitor BP: combo may incr. risk of serious infection, HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Eohilia (budesonide)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    budesonide + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Eohilia (budesonide)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + olodaterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • osilodrostat
  • Eohilia (budesonide)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    budesonide + osilodrostat

    monitor BP, potassium: combo may incr. risk of HTN, hypokalemia (additive effects)

  • oxaprozin
  • Eohilia (budesonide)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    budesonide + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Eohilia (budesonide)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    budesonide + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Eohilia (budesonide)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    budesonide + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Eohilia (budesonide)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    budesonide + ozanimod

    monitor BP; caution advised during and x3mo after ozanimod tx: combo may incr. risk of HTN (including hypertensive crisis), serious infection; infection risk may be prolonged (additive effects)

  • pamidronate
  • Eohilia (budesonide)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    budesonide + pamidronate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • panitumumab
  • Eohilia (budesonide)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    budesonide + panitumumab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • pazopanib
  • Eohilia (budesonide)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    budesonide + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Eohilia (budesonide)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    budesonide + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Eohilia (budesonide)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    budesonide + pexidartinib

    monitor BP: combo may decr. budesonide levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • phendimetrazine
  • Eohilia (budesonide)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    budesonide + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Eohilia (budesonide)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    budesonide + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Eohilia (budesonide)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    budesonide + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Eohilia (budesonide)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    budesonide + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Eohilia (budesonide)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    budesonide + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Eohilia (budesonide)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    budesonide + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Eohilia (budesonide)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    budesonide + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Eohilia (budesonide)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    budesonide + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Eohilia (budesonide)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    budesonide + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Eohilia (budesonide)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    budesonide + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • Eohilia (budesonide)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    budesonide + pioglitazone

    monitor glucose: combo may decr. budesonide levels, efficacy; may decr. antidiabetic agent efficacy (hepatic metabolism induced; antagonistic effects)

  • piroxicam
  • Eohilia (budesonide)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    budesonide + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pneumococcal vaccine
  • Eohilia (budesonide)
    +
    pneumococcal vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + pneumococcal vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • poliovirus vaccine
  • Eohilia (budesonide)
    +
    poliovirus vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + poliovirus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • polyethylene glycol
  • Eohilia (budesonide)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    budesonide + polyethylene glycol

    monitor potassium, consider monitoring ECG if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • polyethylene glycol/electrolytes
  • Eohilia (budesonide)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    budesonide + polyethylene glycol/ electrolytes

    monitor potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • ponatinib
  • Eohilia (budesonide)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + ponatinib

    monitor BP: combo may incr. risk of HTN, serious infection (additive effects)

  • ponesimod
  • Eohilia (budesonide)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    budesonide + ponesimod

    monitor BP; caution advised during and x1-2wk after ponesimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • pralsetinib
  • Eohilia (budesonide)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    budesonide + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pramlintide
  • Eohilia (budesonide)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    budesonide + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Eohilia (budesonide)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    budesonide + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • propranolol
  • Eohilia (budesonide)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    budesonide + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pseudoephedrine
  • Eohilia (budesonide)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    budesonide + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quetiapine
  • Eohilia (budesonide)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    budesonide + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Eohilia (budesonide)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    budesonide + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Eohilia (budesonide)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    budesonide + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Eohilia (budesonide)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    budesonide + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Eohilia (budesonide)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    budesonide + regorafenib

    monitor BP: combo may incr. risk of HTN, serious infection (additive effects)

  • repaglinide
  • Eohilia (budesonide)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    budesonide + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • respiratory syncytial virus vaccine
  • Eohilia (budesonide)
    +
    respiratory syncytial virus vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + respiratory syncytial virus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • rilzabrutinib
  • Eohilia (budesonide)
    +
    rilzabrutinib
    1 interaction

    Monitor/Modify Tx

    budesonide + rilzabrutinib

    monitor hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • rimegepant
  • Eohilia (budesonide)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    budesonide + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Eohilia (budesonide)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    budesonide + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Eohilia (budesonide)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Eohilia (budesonide)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    budesonide + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rosiglitazone
  • Eohilia (budesonide)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    budesonide + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Eohilia (budesonide)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    budesonide + rotigotine transdermal

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sacituzumab govitecan
  • Eohilia (budesonide)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    budesonide + sacituzumab govitecan

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

  • salmeterol inhaled
  • Eohilia (budesonide)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + salmeterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • salsalate
  • Eohilia (budesonide)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    budesonide + salsalate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • saxagliptin
  • Eohilia (budesonide)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    budesonide + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selinexor
  • Eohilia (budesonide)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    budesonide + selinexor

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • selpercatinib
  • Eohilia (budesonide)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    budesonide + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • semaglutide
  • Eohilia (budesonide)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    budesonide + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • siponimod
  • Eohilia (budesonide)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    budesonide + siponimod

    caution advised during and x3-4wk after siponimod tx; monitor BP: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • sipuleucel-T
  • Eohilia (budesonide)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    budesonide + sipuleucel-T

    consider decr. budesonide dose or D/C during leukapheresis and sipuleucel-T admin.: combo may decr. efficacy of sipuleucel-T; may incr. risk of adverse effects (antagonistic effects; additive effects)

  • sirolimus albumin-bound
  • Eohilia (budesonide)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    budesonide + sirolimus albumin-bound

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • sitagliptin
  • Eohilia (budesonide)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    budesonide + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • smallpox/mpox vaccine, live
  • Eohilia (budesonide)
    +
    smallpox/ mpox vaccine, live
    1 interaction

    Monitor/Modify Tx

    budesonide + smallpox/ mpox vaccine, live

    consider vaccinating at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response (immunosuppressive effects)

  • sodium acid phosphate
  • Eohilia (budesonide)
    +
    sodium acid phosphate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium acid phosphate

    monitor sodium: combo may incr. risk of hypernatremia (possible additive effects)

  • sodium benzoate
  • Eohilia (budesonide)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium benzoate

    monitor potassium, especially if hyperammonemia use: combo may incr. risk of hypokalemia (possible additive effects)

  • sodium phenylacetate
  • Eohilia (budesonide)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium phenylacetate

    monitor potassium, ammonia levels: combo may incr. risk of hypokalemia; may decr. sodium phenylacetate efficacy (possible additive effects; antagonistic effects)

  • sodium phenylbutyrate
  • Eohilia (budesonide)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium phenylbutyrate

    monitor potassium, ammonia levels: combo may decr. sodium phenylbutyrate efficacy; may incr. risk of hypokalemia (antagonistic effects; possible additive effects)

  • sodium polystyrene sulfonate
  • Eohilia (budesonide)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium polystyrene sulfonate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • sodium thiosulfate
  • Eohilia (budesonide)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    budesonide + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium; otherwise, caution advised: combo may incr. risk of hypokalemia (possible additive effects)

  • solriamfetol
  • Eohilia (budesonide)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    budesonide + solriamfetol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • somatrogon
  • Eohilia (budesonide)
    +
    somatrogon
    1 interaction

    Monitor/Modify Tx

    budesonide + somatrogon

    consider budesonide dose adjustment: combo may decr. somatrogon efficacy (antagonistic effects)

  • sorafenib
  • Eohilia (budesonide)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    budesonide + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Eohilia (budesonide)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    budesonide + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulfate bowel prep
  • Eohilia (budesonide)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    budesonide + sulfate bowel prep

    monitor potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (possible additive effects)

  • sulindac
  • Eohilia (budesonide)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    budesonide + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Eohilia (budesonide)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Eohilia (budesonide)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    budesonide + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Eohilia (budesonide)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    budesonide + tacrolimus

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • tafasitamab
  • Eohilia (budesonide)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    budesonide + tafasitamab

    monitor potassium: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • tagraxofusp
  • Eohilia (budesonide)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    budesonide + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Eohilia (budesonide)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    budesonide + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Eohilia (budesonide)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    budesonide + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Eohilia (budesonide)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    budesonide + terbutaline

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • teriflunomide
  • Eohilia (budesonide)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    budesonide + teriflunomide

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • testosterone
  • Eohilia (budesonide)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    budesonide + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tick-borne encephalitis vaccine
  • Eohilia (budesonide)
    +
    tick-borne encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + tick-borne encephalitis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • timolol
  • Eohilia (budesonide)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    budesonide + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tirzepatide
  • Eohilia (budesonide)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    budesonide + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Eohilia (budesonide)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    budesonide + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Eohilia (budesonide)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    budesonide + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • topiramate
  • Eohilia (budesonide)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    budesonide + topiramate

    monitor potassium: combo may decr. budesonide levels, efficacy; may incr. risk of hypokalemia (hepatic metabolism induced; possible additive effects)

  • torsemide
  • Eohilia (budesonide)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    budesonide + torsemide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • trametinib
  • Eohilia (budesonide)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    budesonide + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Eohilia (budesonide)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    budesonide + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamterene
  • Eohilia (budesonide)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    budesonide + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • typhoid vaccine
  • Eohilia (budesonide)
    +
    typhoid vaccine
    1 interaction

    Monitor/Modify Tx

    budesonide + typhoid vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ubrogepant
  • Eohilia (budesonide)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    budesonide + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Eohilia (budesonide)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    budesonide + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Eohilia (budesonide)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    budesonide + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vandetanib
  • Eohilia (budesonide)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    budesonide + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Eohilia (budesonide)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    budesonide + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Eohilia (budesonide)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    budesonide + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Eohilia (budesonide)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    budesonide + verapamil

    monitor BP, hypercorticism s/sx: combo may incr. budesonide levels, risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

  • vilanterol inhaled
  • Eohilia (budesonide)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    budesonide + vilanterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • viloxazine
  • Eohilia (budesonide)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    budesonide + viloxazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • voclosporin
  • Eohilia (budesonide)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    budesonide + voclosporin

    monitor BP: combo may incr. risk of HTN, serious infection (additive effects)

  • yohimbe
  • Eohilia (budesonide)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    budesonide + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Eohilia (budesonide)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    budesonide + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Eohilia (budesonide)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    budesonide + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Eohilia (budesonide)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    budesonide + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zonisamide
  • Eohilia (budesonide)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    budesonide + zonisamide

    monitor potassium: combo may incr. risk of hypokalemia (possible additive effects)

Caution Advised

  • abatacept
  • Eohilia (budesonide)
    +
    abatacept
    1 interaction

    Caution Advised

    budesonide + abatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • abemaciclib
  • Eohilia (budesonide)
    +
    abemaciclib
    1 interaction

    Caution Advised

    budesonide + abemaciclib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • abrocitinib
  • Eohilia (budesonide)
    +
    abrocitinib
    1 interaction

    Caution Advised

    budesonide + abrocitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • acalabrutinib
  • Eohilia (budesonide)
    +
    acalabrutinib
    1 interaction

    Caution Advised

    budesonide + acalabrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • adalimumab
  • Eohilia (budesonide)
    +
    adalimumab
    1 interaction

    Caution Advised

    budesonide + adalimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • alemtuzumab
  • Eohilia (budesonide)
    +
    alemtuzumab
    1 interaction

    Caution Advised

    budesonide + alemtuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anakinra
  • Eohilia (budesonide)
    +
    anakinra
    1 interaction

    Caution Advised

    budesonide + anakinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anifrolumab
  • Eohilia (budesonide)
    +
    anifrolumab
    1 interaction

    Caution Advised

    budesonide + anifrolumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anti-thymocyte globulin
  • Eohilia (budesonide)
    +
    anti-thymocyte globulin
    1 interaction

    Caution Advised

    budesonide + anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • apalutamide
  • Eohilia (budesonide)
    +
    apalutamide
    1 interaction

    Caution Advised

    budesonide + apalutamide

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • artemether/lumefantrine
  • Eohilia (budesonide)
    +
    artemether/ lumefantrine
    1 interaction

    Caution Advised

    budesonide + artemether/ lumefantrine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • atidarsagene autotemcel
  • Eohilia (budesonide)
    +
    atidarsagene autotemcel
    1 interaction

    Caution Advised

    budesonide + atidarsagene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azacitidine
  • Eohilia (budesonide)
    +
    azacitidine
    1 interaction

    Caution Advised

    budesonide + azacitidine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azathioprine
  • Eohilia (budesonide)
    +
    azathioprine
    1 interaction

    Caution Advised

    budesonide + azathioprine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • baricitinib
  • Eohilia (budesonide)
    +
    baricitinib
    1 interaction

    Caution Advised

    budesonide + baricitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • beclomethasone inhaled
  • Eohilia (budesonide)
    +
    beclomethasone inhaled
    1 interaction

    Caution Advised

    budesonide + beclomethasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • beclomethasone nasal
  • Eohilia (budesonide)
    +
    beclomethasone nasal
    1 interaction

    Caution Advised

    budesonide + beclomethasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • belatacept
  • Eohilia (budesonide)
    +
    belatacept
    1 interaction

    Caution Advised

    budesonide + belatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belimumab
  • Eohilia (budesonide)
    +
    belimumab
    1 interaction

    Caution Advised

    budesonide + belimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belinostat
  • Eohilia (budesonide)
    +
    belinostat
    1 interaction

    Caution Advised

    budesonide + belinostat

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belzutifan
  • Eohilia (budesonide)
    +
    belzutifan
    1 interaction

    Caution Advised

    budesonide + belzutifan

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • bendamustine
  • Eohilia (budesonide)
    +
    bendamustine
    1 interaction

    Caution Advised

    budesonide + bendamustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bexarotene
  • Eohilia (budesonide)
    +
    bexarotene
    1 interaction

    Caution Advised

    budesonide + bexarotene

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • bimekizumab
  • Eohilia (budesonide)
    +
    bimekizumab
    1 interaction

    Caution Advised

    budesonide + bimekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • blinatumomab
  • Eohilia (budesonide)
    +
    blinatumomab
    1 interaction

    Caution Advised

    budesonide + blinatumomab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bortezomib
  • Eohilia (budesonide)
    +
    bortezomib
    1 interaction

    Caution Advised

    budesonide + bortezomib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bosentan
  • Eohilia (budesonide)
    +
    bosentan
    1 interaction

    Caution Advised

    budesonide + bosentan

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • brentuximab vedotin
  • Eohilia (budesonide)
    +
    brentuximab vedotin
    1 interaction

    Caution Advised

    budesonide + brentuximab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • brodalumab
  • Eohilia (budesonide)
    +
    brodalumab
    1 interaction

    Caution Advised

    budesonide + brodalumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide inhaled
  • Eohilia (budesonide)
    +
    budesonide inhaled
    1 interaction

    Caution Advised

    budesonide + budesonide inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide nasal
  • Eohilia (budesonide)
    +
    budesonide nasal
    1 interaction

    Caution Advised

    budesonide + budesonide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide rectal
  • Eohilia (budesonide)
    +
    budesonide rectal
    1 interaction

    Caution Advised

    budesonide + budesonide rectal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • busulfan
  • Eohilia (budesonide)
    +
    busulfan
    1 interaction

    Caution Advised

    budesonide + busulfan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • butalbital
  • Eohilia (budesonide)
    +
    butalbital
    1 interaction

    Caution Advised

    budesonide + butalbital

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • cabazitaxel
  • Eohilia (budesonide)
    +
    cabazitaxel
    1 interaction

    Caution Advised

    budesonide + cabazitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • canakinumab
  • Eohilia (budesonide)
    +
    canakinumab
    1 interaction

    Caution Advised

    budesonide + canakinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carbamazepine
  • Eohilia (budesonide)
    +
    carbamazepine
    1 interaction

    Caution Advised

    budesonide + carbamazepine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • carboplatin
  • Eohilia (budesonide)
    +
    carboplatin
    1 interaction

    Caution Advised

    budesonide + carboplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carmustine
  • Eohilia (budesonide)
    +
    carmustine
    1 interaction

    Caution Advised

    budesonide + carmustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cenobamate
  • Eohilia (budesonide)
    +
    cenobamate
    1 interaction

    Caution Advised

    budesonide + cenobamate

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • certolizumab pegol
  • Eohilia (budesonide)
    +
    certolizumab pegol
    1 interaction

    Caution Advised

    budesonide + certolizumab pegol

    caution advised: combo may incr. risk of serious infection (additive effects)

  • chlorambucil
  • Eohilia (budesonide)
    +
    chlorambucil
    1 interaction

    Caution Advised

    budesonide + chlorambucil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ciclesonide
  • Eohilia (budesonide)
    +
    ciclesonide
    1 interaction

    Caution Advised

    budesonide + ciclesonide

    caution advised: combo may incr. risk of systemic corticosteroid effects incl. Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • cladribine injection
  • Eohilia (budesonide)
    +
    cladribine injection
    1 interaction

    Caution Advised

    budesonide + cladribine injection

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clobazam
  • Eohilia (budesonide)
    +
    clobazam
    1 interaction

    Caution Advised

    budesonide + clobazam

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • clobetasol ophthalmic
  • Eohilia (budesonide)
    +
    clobetasol ophthalmic
    1 interaction

    Caution Advised

    budesonide + clobetasol ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • clofarabine
  • Eohilia (budesonide)
    +
    clofarabine
    1 interaction

    Caution Advised

    budesonide + clofarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • coccidioides immitis skin test antigen
  • Eohilia (budesonide)
    +
    coccidioides immitis skin test antigen
    1 interaction

    Caution Advised

    budesonide + coccidioides immitis skin test antigen

    caution advised during and after long-term (>2wk) high-dose systemic steroids: combo may interfere with test results (antagonistic effects)

  • crovalimab
  • Eohilia (budesonide)
    +
    crovalimab
    1 interaction

    Caution Advised

    budesonide + crovalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cyclophosphamide
  • Eohilia (budesonide)
    +
    cyclophosphamide
    1 interaction

    Caution Advised

    budesonide + cyclophosphamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cytarabine
  • Eohilia (budesonide)
    +
    cytarabine
    1 interaction

    Caution Advised

    budesonide + cytarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dabrafenib
  • Eohilia (budesonide)
    +
    dabrafenib
    1 interaction

    Caution Advised

    budesonide + dabrafenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • dactinomycin
  • Eohilia (budesonide)
    +
    dactinomycin
    1 interaction

    Caution Advised

    budesonide + dactinomycin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • danicopan
  • Eohilia (budesonide)
    +
    danicopan
    1 interaction

    Caution Advised

    budesonide + danicopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • danshen
  • Eohilia (budesonide)
    +
    danshen
    1 interaction

    Caution Advised

    budesonide + danshen

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • daratumumab
  • Eohilia (budesonide)
    +
    daratumumab
    1 interaction

    Caution Advised

    budesonide + daratumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • darolutamide
  • Eohilia (budesonide)
    +
    darolutamide
    1 interaction

    Caution Advised

    budesonide + darolutamide

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • daunorubicin
  • Eohilia (budesonide)
    +
    daunorubicin
    1 interaction

    Caution Advised

    budesonide + daunorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • delgocitinib topical
  • Eohilia (budesonide)
    +
    delgocitinib topical
    1 interaction

    Caution Advised

    budesonide + delgocitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deucravacitinib
  • Eohilia (budesonide)
    +
    deucravacitinib
    1 interaction

    Caution Advised

    budesonide + deucravacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deuruxolitinib
  • Eohilia (budesonide)
    +
    deuruxolitinib
    1 interaction

    Caution Advised

    budesonide + deuruxolitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dexamethasone ophthalmic
  • Eohilia (budesonide)
    +
    dexamethasone ophthalmic
    1 interaction

    Caution Advised

    budesonide + dexamethasone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • dicloxacillin
  • Eohilia (budesonide)
    +
    dicloxacillin
    1 interaction

    Caution Advised

    budesonide + dicloxacillin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • difluprednate ophthalmic
  • Eohilia (budesonide)
    +
    difluprednate ophthalmic
    1 interaction

    Caution Advised

    budesonide + difluprednate ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • dimethyl fumarate
  • Eohilia (budesonide)
    +
    dimethyl fumarate
    1 interaction

    Caution Advised

    budesonide + dimethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • diroximel fumarate
  • Eohilia (budesonide)
    +
    diroximel fumarate
    1 interaction

    Caution Advised

    budesonide + diroximel fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • docetaxel
  • Eohilia (budesonide)
    +
    docetaxel
    1 interaction

    Caution Advised

    budesonide + docetaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • doxorubicin
  • Eohilia (budesonide)
    +
    doxorubicin
    1 interaction

    Caution Advised

    budesonide + doxorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dupilumab
  • Eohilia (budesonide)
    +
    dupilumab
    1 interaction

    Caution Advised

    budesonide + dupilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • echinacea
  • Eohilia (budesonide)
    +
    echinacea
    1 interaction

    Caution Advised

    budesonide + echinacea

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • eculizumab
  • Eohilia (budesonide)
    +
    eculizumab
    1 interaction

    Caution Advised

    budesonide + eculizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • efavirenz
  • Eohilia (budesonide)
    +
    efavirenz
    1 interaction

    Caution Advised

    budesonide + efavirenz

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • efgartigimod alfa
  • Eohilia (budesonide)
    +
    efgartigimod alfa
    1 interaction

    Caution Advised

    budesonide + efgartigimod alfa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elafibranor
  • Eohilia (budesonide)
    +
    elafibranor
    1 interaction

    Caution Advised

    budesonide + elafibranor

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • elagolix
  • Eohilia (budesonide)
    +
    elagolix
    1 interaction

    Caution Advised

    budesonide + elagolix

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • eleuthero
  • Eohilia (budesonide)
    +
    eleuthero
    1 interaction

    Caution Advised

    budesonide + eleuthero

    caution advised: combo may decr. budesonide efficacy (antagonistic effects)

  • elivaldogene autotemcel
  • Eohilia (budesonide)
    +
    elivaldogene autotemcel
    1 interaction

    Caution Advised

    budesonide + elivaldogene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elotuzumab
  • Eohilia (budesonide)
    +
    elotuzumab
    1 interaction

    Caution Advised

    budesonide + elotuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elranatamab
  • Eohilia (budesonide)
    +
    elranatamab
    1 interaction

    Caution Advised

    budesonide + elranatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • enasidenib
  • Eohilia (budesonide)
    +
    enasidenib
    1 interaction

    Caution Advised

    budesonide + enasidenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • encorafenib
  • Eohilia (budesonide)
    +
    encorafenib
    1 interaction

    Caution Advised

    budesonide + encorafenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Eohilia (budesonide)
    +
    enzalutamide
    1 interaction

    Caution Advised

    budesonide + enzalutamide

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • epcoritamab
  • Eohilia (budesonide)
    +
    epcoritamab
    1 interaction

    Caution Advised

    budesonide + epcoritamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • epirubicin
  • Eohilia (budesonide)
    +
    epirubicin
    1 interaction

    Caution Advised

    budesonide + epirubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eribulin
  • Eohilia (budesonide)
    +
    eribulin
    1 interaction

    Caution Advised

    budesonide + eribulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • eslicarbazepine acetate
  • Eohilia (budesonide)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    budesonide + eslicarbazepine acetate

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • etanercept
  • Eohilia (budesonide)
    +
    etanercept
    1 interaction

    Caution Advised

    budesonide + etanercept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etoposide
  • Eohilia (budesonide)
    +
    etoposide
    1 interaction

    Caution Advised

    budesonide + etoposide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etravirine
  • Eohilia (budesonide)
    +
    etravirine
    1 interaction

    Caution Advised

    budesonide + etravirine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • etuvetidigene autotemcel
  • Eohilia (budesonide)
    +
    etuvetidigene autotemcel
    1 interaction

    Caution Advised

    budesonide + etuvetidigene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • felbamate
  • Eohilia (budesonide)
    +
    felbamate
    1 interaction

    Caution Advised

    budesonide + felbamate

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • fexinidazole
  • Eohilia (budesonide)
    +
    fexinidazole
    1 interaction

    Caution Advised

    budesonide + fexinidazole

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • floxuridine
  • Eohilia (budesonide)
    +
    floxuridine
    1 interaction

    Caution Advised

    budesonide + floxuridine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fludarabine
  • Eohilia (budesonide)
    +
    fludarabine
    1 interaction

    Caution Advised

    budesonide + fludarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • flunisolide nasal
  • Eohilia (budesonide)
    +
    flunisolide nasal
    1 interaction

    Caution Advised

    budesonide + flunisolide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluocinolone intravitreal
  • Eohilia (budesonide)
    +
    fluocinolone intravitreal
    1 interaction

    Caution Advised

    budesonide + fluocinolone intravitreal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluorometholone ophthalmic
  • Eohilia (budesonide)
    +
    fluorometholone ophthalmic
    1 interaction

    Caution Advised

    budesonide + fluorometholone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluticasone furoate
  • Eohilia (budesonide)
    +
    fluticasone furoate
    1 interaction

    Caution Advised

    budesonide + fluticasone furoate

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluticasone propionate
  • Eohilia (budesonide)
    +
    fluticasone propionate
    1 interaction

    Caution Advised

    budesonide + fluticasone propionate

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fosamprenavir
  • Eohilia (budesonide)
    +
    fosamprenavir
    1 interaction

    Caution Advised

    budesonide + fosamprenavir

    caution advised: combo may incr. or decr. budesonide levels, incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects or decr. efficacy (hepatic metabolism altered)

  • fosphenytoin
  • Eohilia (budesonide)
    +
    fosphenytoin
    1 interaction

    Caution Advised

    budesonide + fosphenytoin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • garlic
  • Eohilia (budesonide)
    +
    garlic
    1 interaction

    Caution Advised

    budesonide + garlic

    caution advised w/ supplemental garlic; dietary intake OK: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • gemtuzumab ozogamicin
  • Eohilia (budesonide)
    +
    gemtuzumab ozogamicin
    1 interaction

    Caution Advised

    budesonide + gemtuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ginkgo
  • Eohilia (budesonide)
    +
    ginkgo
    1 interaction

    Caution Advised

    budesonide + ginkgo

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • ginseng, Asian
  • Eohilia (budesonide)
    +
    ginseng, Asian
    1 interaction

    Caution Advised

    budesonide + ginseng, Asian

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • glofitamab
  • Eohilia (budesonide)
    +
    glofitamab
    1 interaction

    Caution Advised

    budesonide + glofitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • golimumab
  • Eohilia (budesonide)
    +
    golimumab
    1 interaction

    Caution Advised

    budesonide + golimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • griseofulvin
  • Eohilia (budesonide)
    +
    griseofulvin
    1 interaction

    Caution Advised

    budesonide + griseofulvin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • guselkumab
  • Eohilia (budesonide)
    +
    guselkumab
    1 interaction

    Caution Advised

    budesonide + guselkumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • hydrocortisone ophthalmic
  • Eohilia (budesonide)
    +
    hydrocortisone ophthalmic
    1 interaction

    Caution Advised

    budesonide + hydrocortisone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • hydroxyurea
  • Eohilia (budesonide)
    +
    hydroxyurea
    1 interaction

    Caution Advised

    budesonide + hydroxyurea

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibritumomab tiuxetan
  • Eohilia (budesonide)
    +
    ibritumomab tiuxetan
    1 interaction

    Caution Advised

    budesonide + ibritumomab tiuxetan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • icotrokinra
  • Eohilia (budesonide)
    +
    icotrokinra
    1 interaction

    Caution Advised

    budesonide + icotrokinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idarubicin
  • Eohilia (budesonide)
    +
    idarubicin
    1 interaction

    Caution Advised

    budesonide + idarubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ifosfamide
  • Eohilia (budesonide)
    +
    ifosfamide
    1 interaction

    Caution Advised

    budesonide + ifosfamide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inebilizumab
  • Eohilia (budesonide)
    +
    inebilizumab
    1 interaction

    Caution Advised

    budesonide + inebilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • infliximab
  • Eohilia (budesonide)
    +
    infliximab
    1 interaction

    Caution Advised

    budesonide + infliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inotuzumab ozogamicin
  • Eohilia (budesonide)
    +
    inotuzumab ozogamicin
    1 interaction

    Caution Advised

    budesonide + inotuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • iptacopan
  • Eohilia (budesonide)
    +
    iptacopan
    1 interaction

    Caution Advised

    budesonide + iptacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • irinotecan
  • Eohilia (budesonide)
    +
    irinotecan
    1 interaction

    Caution Advised

    budesonide + irinotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isatuximab
  • Eohilia (budesonide)
    +
    isatuximab
    1 interaction

    Caution Advised

    budesonide + isatuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isotretinoin
  • Eohilia (budesonide)
    +
    isotretinoin
    1 interaction

    Caution Advised

    budesonide + isotretinoin

    caution advised: combo may incr. risk of bone loss (additive effects)

  • ivosidenib
  • Eohilia (budesonide)
    +
    ivosidenib
    1 interaction

    Caution Advised

    budesonide + ivosidenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • ixabepilone
  • Eohilia (budesonide)
    +
    ixabepilone
    1 interaction

    Caution Advised

    budesonide + ixabepilone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixekizumab
  • Eohilia (budesonide)
    +
    ixekizumab
    1 interaction

    Caution Advised

    budesonide + ixekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lebrikizumab
  • Eohilia (budesonide)
    +
    lebrikizumab
    1 interaction

    Caution Advised

    budesonide + lebrikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • linvoseltamab
  • Eohilia (budesonide)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    budesonide + linvoseltamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lomustine
  • Eohilia (budesonide)
    +
    lomustine
    1 interaction

    Caution Advised

    budesonide + lomustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loncastuximab tesirine
  • Eohilia (budesonide)
    +
    loncastuximab tesirine
    1 interaction

    Caution Advised

    budesonide + loncastuximab tesirine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loteprednol ophthalmic
  • Eohilia (budesonide)
    +
    loteprednol ophthalmic
    1 interaction

    Caution Advised

    budesonide + loteprednol ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Eohilia (budesonide)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Caution Advised

    budesonide + lymphocyte immune globulin, anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection, mask anti-thymocyte globulin adverse reactions (additive effects)

  • marnetegragene autotemcel
  • Eohilia (budesonide)
    +
    marnetegragene autotemcel
    1 interaction

    Caution Advised

    budesonide + marnetegragene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mavacamten
  • Eohilia (budesonide)
    +
    mavacamten
    1 interaction

    Caution Advised

    budesonide + mavacamten

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • melphalan
  • Eohilia (budesonide)
    +
    melphalan
    1 interaction

    Caution Advised

    budesonide + melphalan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mercaptopurine
  • Eohilia (budesonide)
    +
    mercaptopurine
    1 interaction

    Caution Advised

    budesonide + mercaptopurine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • meropenem
  • Eohilia (budesonide)
    +
    meropenem
    1 interaction

    Caution Advised

    budesonide + meropenem

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism possibly induced)

  • methotrexate
  • Eohilia (budesonide)
    +
    methotrexate
    1 interaction

    Caution Advised

    budesonide + methotrexate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mirikizumab
  • Eohilia (budesonide)
    +
    mirikizumab
    1 interaction

    Caution Advised

    budesonide + mirikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mitapivat
  • Eohilia (budesonide)
    +
    mitapivat
    1 interaction

    Caution Advised

    budesonide + mitapivat

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • mitoxantrone
  • Eohilia (budesonide)
    +
    mitoxantrone
    1 interaction

    Caution Advised

    budesonide + mitoxantrone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mobocertinib
  • Eohilia (budesonide)
    +
    mobocertinib
    1 interaction

    Caution Advised

    budesonide + mobocertinib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • mogamulizumab
  • Eohilia (budesonide)
    +
    mogamulizumab
    1 interaction

    Caution Advised

    budesonide + mogamulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • momelotinib
  • Eohilia (budesonide)
    +
    momelotinib
    1 interaction

    Caution Advised

    budesonide + momelotinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone implant
  • Eohilia (budesonide)
    +
    mometasone implant
    1 interaction

    Caution Advised

    budesonide + mometasone implant

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone inhaled
  • Eohilia (budesonide)
    +
    mometasone inhaled
    1 interaction

    Caution Advised

    budesonide + mometasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone nasal
  • Eohilia (budesonide)
    +
    mometasone nasal
    1 interaction

    Caution Advised

    budesonide + mometasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • monomethyl fumarate
  • Eohilia (budesonide)
    +
    monomethyl fumarate
    1 interaction

    Caution Advised

    budesonide + monomethyl fumarate

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mosunetuzumab
  • Eohilia (budesonide)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    budesonide + mosunetuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolate mofetil
  • Eohilia (budesonide)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    budesonide + mycophenolate mofetil

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mycophenolic acid
  • Eohilia (budesonide)
    +
    mycophenolic acid
    1 interaction

    Caution Advised

    budesonide + mycophenolic acid

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nadofaragene firadenovec intravesical
  • Eohilia (budesonide)
    +
    nadofaragene firadenovec intravesical
    1 interaction

    Caution Advised

    budesonide + nadofaragene firadenovec intravesical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • nafcillin
  • Eohilia (budesonide)
    +
    nafcillin
    1 interaction

    Caution Advised

    budesonide + nafcillin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • narsoplimab
  • Eohilia (budesonide)
    +
    narsoplimab
    1 interaction

    Caution Advised

    budesonide + narsoplimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nelarabine
  • Eohilia (budesonide)
    +
    nelarabine
    1 interaction

    Caution Advised

    budesonide + nelarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nevirapine
  • Eohilia (budesonide)
    +
    nevirapine
    1 interaction

    Caution Advised

    budesonide + nevirapine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • nipocalimab
  • Eohilia (budesonide)
    +
    nipocalimab
    1 interaction

    Caution Advised

    budesonide + nipocalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ocrelizumab
  • Eohilia (budesonide)
    +
    ocrelizumab
    1 interaction

    Caution Advised

    budesonide + ocrelizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • odevixibat
  • Eohilia (budesonide)
    +
    odevixibat
    1 interaction

    Caution Advised

    budesonide + odevixibat

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • ofatumumab
  • Eohilia (budesonide)
    +
    ofatumumab
    1 interaction

    Caution Advised

    budesonide + ofatumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • olutasidenib
  • Eohilia (budesonide)
    +
    olutasidenib
    1 interaction

    Caution Advised

    budesonide + olutasidenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism possibly induced)

  • omaveloxolone
  • Eohilia (budesonide)
    +
    omaveloxolone
    1 interaction

    Caution Advised

    budesonide + omaveloxolone

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • oxaliplatin
  • Eohilia (budesonide)
    +
    oxaliplatin
    1 interaction

    Caution Advised

    budesonide + oxaliplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • oxcarbazepine
  • Eohilia (budesonide)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    budesonide + oxcarbazepine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • paclitaxel
  • Eohilia (budesonide)
    +
    paclitaxel
    1 interaction

    Caution Advised

    budesonide + paclitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pacritinib
  • Eohilia (budesonide)
    +
    pacritinib
    1 interaction

    Caution Advised

    budesonide + pacritinib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • pegcetacoplan
  • Eohilia (budesonide)
    +
    pegcetacoplan
    1 interaction

    Caution Advised

    budesonide + pegcetacoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pentobarbital
  • Eohilia (budesonide)
    +
    pentobarbital
    1 interaction

    Caution Advised

    budesonide + pentobarbital

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • pentostatin
  • Eohilia (budesonide)
    +
    pentostatin
    1 interaction

    Caution Advised

    budesonide + pentostatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • perampanel
  • Eohilia (budesonide)
    +
    perampanel
    1 interaction

    Caution Advised

    budesonide + perampanel

    caution advised if on perampanel 12 mg/day: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • phenobarbital
  • Eohilia (budesonide)
    +
    phenobarbital
    1 interaction

    Caution Advised

    budesonide + phenobarbital

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • phenytoin
  • Eohilia (budesonide)
    +
    phenytoin
    1 interaction

    Caution Advised

    budesonide + phenytoin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • pirtobrutinib
  • Eohilia (budesonide)
    +
    pirtobrutinib
    1 interaction

    Caution Advised

    budesonide + pirtobrutinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • polatuzumab vedotin
  • Eohilia (budesonide)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    budesonide + polatuzumab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pomalidomide
  • Eohilia (budesonide)
    +
    pomalidomide
    1 interaction

    Caution Advised

    budesonide + pomalidomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pozelimab
  • Eohilia (budesonide)
    +
    pozelimab
    1 interaction

    Caution Advised

    budesonide + pozelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • prednisolone ophthalmic
  • Eohilia (budesonide)
    +
    prednisolone ophthalmic
    1 interaction

    Caution Advised

    budesonide + prednisolone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • primidone
  • Eohilia (budesonide)
    +
    primidone
    1 interaction

    Caution Advised

    budesonide + primidone

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • procarbazine
  • Eohilia (budesonide)
    +
    procarbazine
    1 interaction

    Caution Advised

    budesonide + procarbazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ravulizumab
  • Eohilia (budesonide)
    +
    ravulizumab
    1 interaction

    Caution Advised

    budesonide + ravulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • repotrectinib
  • Eohilia (budesonide)
    +
    repotrectinib
    1 interaction

    Caution Advised

    budesonide + repotrectinib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • rifabutin
  • Eohilia (budesonide)
    +
    rifabutin
    1 interaction

    Caution Advised

    budesonide + rifabutin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Eohilia (budesonide)
    +
    rifampin
    1 interaction

    Caution Advised

    budesonide + rifampin

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • rifapentine
  • Eohilia (budesonide)
    +
    rifapentine
    1 interaction

    Caution Advised

    budesonide + rifapentine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • rilonacept
  • Eohilia (budesonide)
    +
    rilonacept
    1 interaction

    Caution Advised

    budesonide + rilonacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • risankizumab
  • Eohilia (budesonide)
    +
    risankizumab
    1 interaction

    Caution Advised

    budesonide + risankizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ritlecitinib
  • Eohilia (budesonide)
    +
    ritlecitinib
    1 interaction

    Caution Advised

    budesonide + ritlecitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rituximab
  • Eohilia (budesonide)
    +
    rituximab
    1 interaction

    Caution Advised

    budesonide + rituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • romidepsin
  • Eohilia (budesonide)
    +
    romidepsin
    1 interaction

    Caution Advised

    budesonide + romidepsin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ropeginterferon alfa-2b
  • Eohilia (budesonide)
    +
    ropeginterferon alfa-2b
    1 interaction

    Caution Advised

    budesonide + ropeginterferon alfa-2b

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rozanolixizumab
  • Eohilia (budesonide)
    +
    rozanolixizumab
    1 interaction

    Caution Advised

    budesonide + rozanolixizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rufinamide
  • Eohilia (budesonide)
    +
    rufinamide
    1 interaction

    Caution Advised

    budesonide + rufinamide

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • ruxolitinib
  • Eohilia (budesonide)
    +
    ruxolitinib
    1 interaction

    Caution Advised

    budesonide + ruxolitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ruxolitinib topical
  • Eohilia (budesonide)
    +
    ruxolitinib topical
    1 interaction

    Caution Advised

    budesonide + ruxolitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sarilumab
  • Eohilia (budesonide)
    +
    sarilumab
    1 interaction

    Caution Advised

    budesonide + sarilumab

    caution advised: combo may decr. budesonide levels, efficacy; may incr. risk of serious infection (hepatic metabolism altered; sarilumab may reverse inflammatory cytokine-induced downregulation of CYP450 enzymes resulting in relative induction of enzymes upon tx start and downregulation upon D/C; additive effects)

  • satralizumab
  • Eohilia (budesonide)
    +
    satralizumab
    1 interaction

    Caution Advised

    budesonide + satralizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • secukinumab
  • Eohilia (budesonide)
    +
    secukinumab
    1 interaction

    Caution Advised

    budesonide + secukinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sibeprenlimab
  • Eohilia (budesonide)
    +
    sibeprenlimab
    1 interaction

    Caution Advised

    budesonide + sibeprenlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siltuximab
  • Eohilia (budesonide)
    +
    siltuximab
    1 interaction

    Caution Advised

    budesonide + siltuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sirolimus
  • Eohilia (budesonide)
    +
    sirolimus
    1 interaction

    Caution Advised

    budesonide + sirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sotorasib
  • Eohilia (budesonide)
    +
    sotorasib
    1 interaction

    Caution Advised

    budesonide + sotorasib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • spesolimab
  • Eohilia (budesonide)
    +
    spesolimab
    1 interaction

    Caution Advised

    budesonide + spesolimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • St. John's wort
  • Eohilia (budesonide)
    +
    St. John's wort
    1 interaction

    Caution Advised

    budesonide + St. John's wort

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • stiripentol
  • Eohilia (budesonide)
    +
    stiripentol
    1 interaction

    Caution Advised

    budesonide + stiripentol

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism possibly induced)

  • sulfasalazine
  • Eohilia (budesonide)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    budesonide + sulfasalazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sunvozertinib
  • Eohilia (budesonide)
    +
    sunvozertinib
    1 interaction

    Caution Advised

    budesonide + sunvozertinib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • sutimlimab
  • Eohilia (budesonide)
    +
    sutimlimab
    1 interaction

    Caution Advised

    budesonide + sutimlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • suzetrigine
  • Eohilia (budesonide)
    +
    suzetrigine
    1 interaction

    Caution Advised

    budesonide + suzetrigine

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • talquetamab
  • Eohilia (budesonide)
    +
    talquetamab
    1 interaction

    Caution Advised

    budesonide + talquetamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tarlatamab
  • Eohilia (budesonide)
    +
    tarlatamab
    1 interaction

    Caution Advised

    budesonide + tarlatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tazemetostat
  • Eohilia (budesonide)
    +
    tazemetostat
    1 interaction

    Caution Advised

    budesonide + tazemetostat

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • teclistamab
  • Eohilia (budesonide)
    +
    teclistamab
    1 interaction

    Caution Advised

    budesonide + teclistamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tecovirimat
  • Eohilia (budesonide)
    +
    tecovirimat
    1 interaction

    Caution Advised

    budesonide + tecovirimat

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • telotristat ethyl
  • Eohilia (budesonide)
    +
    telotristat ethyl
    1 interaction

    Caution Advised

    budesonide + telotristat ethyl

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • temozolomide
  • Eohilia (budesonide)
    +
    temozolomide
    1 interaction

    Caution Advised

    budesonide + temozolomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temsirolimus
  • Eohilia (budesonide)
    +
    temsirolimus
    1 interaction

    Caution Advised

    budesonide + temsirolimus

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teplizumab
  • Eohilia (budesonide)
    +
    teplizumab
    1 interaction

    Caution Advised

    budesonide + teplizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teriparatide
  • Eohilia (budesonide)
    +
    teriparatide
    1 interaction

    Caution Advised

    budesonide + teriparatide

    caution advised: combo may incr. risk of calciphylaxis (additive effects)

  • tezepelumab
  • Eohilia (budesonide)
    +
    tezepelumab
    1 interaction

    Caution Advised

    budesonide + tezepelumab

    caution advised w/ high-dose systemic corticosteroid use: combo may incr. risk of serious infection (possible additive effects)

  • thioguanine
  • Eohilia (budesonide)
    +
    thioguanine
    1 interaction

    Caution Advised

    budesonide + thioguanine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thiotepa
  • Eohilia (budesonide)
    +
    thiotepa
    1 interaction

    Caution Advised

    budesonide + thiotepa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tildrakizumab
  • Eohilia (budesonide)
    +
    tildrakizumab
    1 interaction

    Caution Advised

    budesonide + tildrakizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tocilizumab
  • Eohilia (budesonide)
    +
    tocilizumab
    1 interaction

    Caution Advised

    budesonide + tocilizumab

    caution advised: combo may decr. budesonide levels, efficacy; may incr. risk of serious infection (hepatic metabolism altered; tocilizumab may reverse inflammatory cytokine-induced downregulation of CYP450 enzymes resulting in relative induction of enzymes; additive effects)

  • tofacitinib
  • Eohilia (budesonide)
    +
    tofacitinib
    1 interaction

    Caution Advised

    budesonide + tofacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • topotecan
  • Eohilia (budesonide)
    +
    topotecan
    1 interaction

    Caution Advised

    budesonide + topotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tovorafenib
  • Eohilia (budesonide)
    +
    tovorafenib
    1 interaction

    Caution Advised

    budesonide + tovorafenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • trabectedin
  • Eohilia (budesonide)
    +
    trabectedin
    1 interaction

    Caution Advised

    budesonide + trabectedin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tralokinumab
  • Eohilia (budesonide)
    +
    tralokinumab
    1 interaction

    Caution Advised

    budesonide + tralokinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tuberculin purified protein derivative
  • Eohilia (budesonide)
    +
    tuberculin purified protein derivative
    1 interaction

    Caution Advised

    budesonide + tuberculin purified protein derivative

    caution advised during and x5-6wk after budesonide tx: combo may interfere with test results (antagonistic effects)

  • ublituximab
  • Eohilia (budesonide)
    +
    ublituximab
    1 interaction

    Caution Advised

    budesonide + ublituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • upadacitinib
  • Eohilia (budesonide)
    +
    upadacitinib
    1 interaction

    Caution Advised

    budesonide + upadacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ustekinumab
  • Eohilia (budesonide)
    +
    ustekinumab
    1 interaction

    Caution Advised

    budesonide + ustekinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vaborbactam
  • Eohilia (budesonide)
    +
    vaborbactam
    1 interaction

    Caution Advised

    budesonide + vaborbactam

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism possibly induced)

  • vedolizumab
  • Eohilia (budesonide)
    +
    vedolizumab
    1 interaction

    Caution Advised

    budesonide + vedolizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vemurafenib
  • Eohilia (budesonide)
    +
    vemurafenib
    1 interaction

    Caution Advised

    budesonide + vemurafenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • venetoclax
  • Eohilia (budesonide)
    +
    venetoclax
    1 interaction

    Caution Advised

    budesonide + venetoclax

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vilobelimab
  • Eohilia (budesonide)
    +
    vilobelimab
    1 interaction

    Caution Advised

    budesonide + vilobelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinblastine
  • Eohilia (budesonide)
    +
    vinblastine
    1 interaction

    Caution Advised

    budesonide + vinblastine

    caution advised: combo may decr. budesonide levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • vincristine
  • Eohilia (budesonide)
    +
    vincristine
    1 interaction

    Caution Advised

    budesonide + vincristine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinorelbine
  • Eohilia (budesonide)
    +
    vinorelbine
    1 interaction

    Caution Advised

    budesonide + vinorelbine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vorasidenib
  • Eohilia (budesonide)
    +
    vorasidenib
    1 interaction

    Caution Advised

    budesonide + vorasidenib

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism possibly induced)

  • zanubrutinib
  • Eohilia (budesonide)
    +
    zanubrutinib
    1 interaction

    Caution Advised

    budesonide + zanubrutinib

    caution advised: combo may decr. budesonide levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • zilucoplan
  • Eohilia (budesonide)
    +
    zilucoplan
    1 interaction

    Caution Advised

    budesonide + zilucoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@72292724
  • anaphylaxis
  • intracranial HTN
  • HTN
  • infection
  • GI obstruction
  • diabetes mellitus
  • adrenal insufficiency
  • Cushing syndrome (long-term use)
  • immunosuppression (long-term use)
  • Kaposi sarcoma (long-term use)
  • glaucoma (long-term use)
  • cataracts (long-term use)
  • osteoporosis (long-term use)
  • withdrawal symptoms if abrupt D/C (long-term use)
  • growth suppression (long-term use in peds patients)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@46a5b64
  • URI
  • candidiasis, oral
  • candidiasis, esophageal
  • headache
  • gastroenteritis
  • throat irritation
  • adrenal suppression
  • erosive esophagitis

Safety/Monitoring .

Monitoring Parameters
TB, HBV screening at baseline; electrolytes; 2h postprandial glucose; BP; weight; height (peds); consider BMD, chest x-ray, endoscopic evaluation, ophthalmic exam; consider upper GI x-ray if PUD history or significant dyspepsia

Look/Sound-Alike Drug Names
budesonide confused with: bumetanide

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 1st trimester or if long-term use; inadequate human data available, though possible risk of orofacial cleft, low birth wt, and premature birth based on conflicting human data with other systemic corticosteroids; possible risk of fetal harm, including teratogenicity and fetal death, based on animal data with SC route at 0.03-1.2x recommended human dose; possible risk of fetal adrenal suppression based on drug's mechanism of action

Lactation

Clinical Summary

weigh risk/benefit if prolonged high-dose use, otherwise may use while breastfeeding; inadequate human data available, though risk of infant harm not expected based on limited drug excretion into milk; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@3860854

Metabolism: for budesonide: liver extensively; CYP450: 3A4 substrate

Excretion: for budesonide: urine 60% (none unchanged), feces; Half-life: 3.3h

Subclass: Corticosteroids, Systemic

Mechanism of Action
for budesonide: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Takeda Pharmaceuticals North America, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@4c999df7

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information